TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
DMRC

Digimarc Corporation

Technology · Software - Application

4.90$ +0.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow DMRC
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-16.0% 7.9% 19.7% 4.1% 33.5% 28.4% 35.2% 9.9% -26.2% -43.9% -63.6% -69.8% -100.1% -97.5% -84.8% -98.5% -147.1% -63.1% -69.2% -34.7%
5.6% 4.7% 3.9% 3.1% 2.1% 2.0% 2.2% 5.7% 9.0% 11.0% 11.3% 9.6% 10.1% 9.6% 11.6% 9.6% 28.4% 23.3% 19.8% 19.1%
7.1% – 7.3% 12.8% 9.8% 11.7% 11.8% 12.9% 21.1% 22.9% 25.5% 26.8% 34.4% 35.7% 38.0% 45.0% 37.4% 32.0% 26.1% 35.3%
– – – – – 8.4% 6.8% 9.8% 29.1% 25.0% 25.5% 26.8% 34.4% 35.7% 38.0% 28.5% 37.7% – – –
-4.3% -6.5% -0.8% -1.0% 1.2% -0.7% -0.9% -1.7% -2.7% 3.1% -0.9% -4.1% 8.8% 0.0% 2.1% -5.5% -18.2% 12.6% -13.5% -0.9%
4.8% 2.8% 6.7% 6.8% 5.4% 3.8% 3.9% 7.8% 10.1% 9.5% 12.1% 11.9% 9.6% 7.5% 6.8% 5.9% 4.9% 2.1% 0.6% 1.7%
1.8% -30.2% -125.1% -48.9% -32.7% 17.1% -22.0% -4.9% -17.1% -23.4% -71.1% 75.2% 40.1% -47.6% -141.1% 98.0% 12.4% 36.0% -29.4% 35.7%
– – – 0.2% – 0.0% 5.3% 9.2% 6.4% 0.0% 0.0% 0.0% – – 1.0% – 0.1% – – –
– – – -9.1% -18.7% -61.2% -10.7% -5.2% -9.3% -11.0% -11.6% -12.0% -9.9% -15.3% -15.7% -21.8% -7.8% -7.8% -8.9% -8.5%
– – – – – – – – – – – 20.0% 23.7% 21.9% 21.0% -0.1% -0.1% -0.1% -0.1% -0.1%
30.7% -7.8% 53.7% -7.9% -8.9% -53.6% -5.4% -13.8% 52.3% 53.9% 173.6% 110.4% -3.9% 75.2% 261.3% -21.8% 200.3% -7.9% 74.9% -8.6%
16.5% -30.2% -51.6% -16.4% -8.2% -8.1% 7.8% -8.7% 9.0% -13.3% 38.9% 115.8% -63.9% -69.9% 35.4% -22.3% 36.2% -34.8% -23.7% -7.5%
-20.8% 5.1% 13.0% -2.7% 28.0% 24.6% 31.2% 2.1% -36.3% -53.4% -75.7% -81.8% -109.7% -105.0% -91.6% -104.4% -151.9% -65.2% -69.7% -36.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?